Ozempic and Wegovy May Increase Hair Loss Risk in Some Men

Recent findings suggest that GLP-1 medications including Ozempic, Wegovy, and Zepbound may increase hair loss risk by 7% in men genetically predisposed to male-pattern baldness. Rather than being solely caused by rapid weight loss, the hair thinning may reflect a biological connection between GLP-1 activity and hair follicles. These popular medications, widely used for weight management and diabetes treatment, warrant closer monitoring for this potential side effect. Men considering or currently using these drugs should discuss any hair changes with their healthcare provider to determine appropriate management strategies.

Originally published on
ScienceDaily Health
Read full article(opens in new tab)Fetched: September 13, 2026 at 10:00 AM



